莆田招聘

职位描述：
About the department

Novo Nordisk is a focused healthcare company and a world leader in diabetes care. Novo Nordisk R&D Centre China (NNRCC) is an integrated part of Novo Nordisk R&D organization. NNRCC currently has a new position open for a highly qualified and motivated scientist with expertise in metabolic disorder areas (such as diabetes and obesity) who plans to advance a career in China.

The department consists of Rodent Pharmacology, Dog Pharmacology and Histopathology in Discovery Biology China (DBC) at NNRCC. The Rodent Pharmacology team is responsible for supporting diabetes and obesity research projects and new target discovery/validation. We are a highly motivated and productive department with high standards for our deliveries into the projects.

The position
Take responsibility in various project supports and discovery/validation of new therapeutic targets in areas of diabetes and obesity, by leading in vivo pharmacology studies at NNRCC/DBC. You will plan and conduct in vivo studies, set-up, develop and evaluate models based on project needs. Furthermore, you will be expected to leverage the innovation culture, mentor colleagues, and promote the collaboration culture both internally and globally.

You will be involved in cross-functional project teams with colleagues from many different scientific backgrounds both in China and in Denmark. You will be a key person in research projects and responsible for defining the direction of the in vivo pharmacology and/or ex vivo biology in the project. You will be the department representative in research projects where you are expected to seek influence based on the data you generate and by keeping up to date with the scientific literature.

You will be referring directly to the department head and your main internal contacts in your daily work will be scientist colleagues, research associates, project members, and managers both in Beijing and in Denmark. Furthermore, developing and maintaining a strong external network is also going to be an important part of your work.

You will be part of a team in a highly dynamic and challenging environment within the Novo Nordisk Diabetes Research Unit.


Qualifications

Ph.D. in Pharmacology or a scientific discipline
5-8 years research experience as Scientist or PI in research and/or development environment. Extensive experience within pharmaceutical R&D is a plus.
Demonstrated success in technical proficiency in the research field, expertise in in vivo pharmacology.
Strong background, knowledge and skillsets in metabolic disease research; experienced in diabetes and obesity animal models.
Excellent track records of innovation, independence and scientific accomplishments of high value.
Excellent communication skills.

You need to have good communication and collaboration skills as you will play a key role in representing your expertise area in global project teams and towards colleagues at the other research sites. You are flexible, open to new ideas, ambitious, innovative and result oriented. You have a lot of individual responsibility with a high degree of personal impact in the projects. You are able to meet deadlines and keep overview. Furthermore, you are fluent in English.

Title and compensation will be commensurate with the applicant’s qualifications and based on benchmark in China.


Working at Novo Nordisk

Working at Novo Nordisk, your skills, dedication and ambition help us change lives for the better. In exchange, we offer you an opportunity to work with extraordinary talent and benefit from a range of possibilities for professional and personal development 举报 分享

诺和诺德在中国
诺和诺德是中国市场的领导者，一直以改变为己任。诺和诺德（中国）制药有限公司于1994年成立，二十几年来业务一直保持强劲增长。公司总部设在北京，产品和服务遍及全国所有省、直辖市及中国港澳台地区。截至2017年底，诺和诺德在华员工总数4329人。诺和诺德是在中国建立研发中心的生物制药公司。位于北京的研发中心是诺和诺德全球研发体系的组成部分，致力于与总部合作研发新产品及新生产工艺。诺和诺德在中国的生产厂位于天津，是公司的国际化战略生产基地。公司对工厂提供了大量的资金投入和技术支持，向全球以及中国市场供应产品。诺和诺德在中国的不断发展反映了公司对中国市场的承诺。

Novo Nordisk in China
As the leader in the Chinese market, Novo Nordisk has always been committed to Changing.
Founded in 1994 and headquartered in Beijing, Novo Nordisk’s presence in China has been growing for more than 20 years.Headquartered in Beijing, providing products and services across mainland China as well as Hong Kong, Macau and Taiwan of China. As of the end of 2017, Novo Nordisk employed over 4,329 employees in China.